In BC progression, dysregulation of the PI3K/Akt/mTOR pathway frequently arises due to genetic alterations, including mutations in PIK3CA, Akt, and mTOR, as well as overexpression of RTKs or loss of PTEN function [201]. This evidence concerns the gene AKT1 and breast cancer.